“With a rescheduling or descheduling status still on the horizon, we will continue our involvement at the federal level to help push progress forward,” Archos said. “We ultimately anticipate that some form of federal action will create large changes for the industry, including the possibility of an uplisting to U.S. exchanges.”
Uplisting to the New York Stock Exchange or the Nasdaq could open the capital floodgates for many public cannabis companies and offer significant financial relief for operators such as Verano.
Read the full story at Crain’s sister publication Green Market Report.
Recent Comments